Overview

A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This one-year study is designed to investigate the safety and efficacy of TPX-100, a 23-amino acid chondrogenic peptide, delivered by intra-articular injection, in regeneration of knee cartilage in subjects with bilateral osteoarthritis of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
OrthoTrophix, Inc